EUVIMEDEUVIMED entdecken
Crossref

Contemporary Perioperative Outcomes of Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer

Zhiyu Qian, Kevin Zhangxu, Christopher J Magnani, Vincent D D'Andrea, Guilherme Garcia Barros, Giuliano B Guglielmetti, Rafael F Coelho, Miguel Amer Mestre, Stephan Korn, Hanna Zurl, Klara Pohl, Andrea Piccolini und 5 weitere

Journal of Endourology · 01.07.2026 · 40 (7) · 766-772

DOI: 10.1177/08927790261451073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Endourology, online erschienen am 21.05.2026. Verfasst von Zhiyu Qian und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Testicular Neoplasms, Lymph Node Excision, Robotic Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: WestWind Foundation, Brigham Department of Urology Institutional Grant.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Robotic retroperitoneal lymph node dissection (R-RPLND) is increasingly recognized as a treatment option for testicular cancer. This study reports contemporary perioperative outcomes from a single institution and examines national trends in R-RPLND adoption.

Methods

We retrospectively reviewed patients who underwent R-RPLND at our institution between December 2022 and November 2024. Clinical and perioperative metrics were collected and analyzed using univariable statistical tests. National trends in R-RPLND utilization were assessed using data from the National Cancer Database from 2012 to 2021. Multivariable logistic regression was performed to evaluate factors associated with the use of R-RPLND.

Results

At our institution, 31 men underwent R-RPLND. The average length of stay was 1.4 days, and the average estimated blood loss was 60.3 mL. The 30-day complication rate was 3.2%, representing one case of chylous ascites. Nationally, R-RPLND utilization increased from 2.5% in 2012 to 8.3% in 2021. Patients with stages II and III disease were less likely to receive robotic surgery compared to those with stage I disease (odds ratio [OR]: 0.383, 95% confidence interval [CI]: 0.167–0.880, p = 0.024 for stage II; OR: 0.231, 95% CI: 0.098–0.545, p = 0.001 for stage III). No 90-day mortality rate was observed in either cohort.

Conclusion

R-RPLND demonstrates favorable perioperative outcomes at both institutional and national levels, with increasing utilization over the past decade. The minimally invasive approach may reduce the morbidity of open surgery and serve as an alternative to chemoradiation in early-stage testicular cancer in selected patients. Further studies are needed to evaluate long-term oncologic outcomes and cost-effectiveness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsLymph Node ExcisionRobotic Surgical ProceduresHumansMaleRetroperitoneal SpaceTreatment OutcomeAdultRetrospective StudiesMiddle AgedPerioperative Period

Stichwörter der Autor:innen

minimally invasive surgeryoutcomesretroperitoneal lymph node dissectionrobotic surgerytesticular cancer

Autor:innen und Institutionen

  • Department of Urology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Center of Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Urology, Universidade de Sao Paulo, Sao Paulo, Brazil.
  • Department of Urology, University Hospital of Son Espases, Mallorca, Spain.
  • Department of Urology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.

Förderung

  • WestWind Foundation
  • Brigham Department of Urology Institutional Grant

Zitieren

APA

Qian, Z., Zhangxu, K., Magnani, C. J., D'Andrea, V. D., Barros, G. G., Guglielmetti, G. B., Coelho, R. F., Mestre, M. A., Korn, S., Zurl, H., Pohl, K., Piccolini, A., Mossanen, M., Trinh, Q. D., Cole, A. P., Kibel, A. S., & Clinton, T. N. (2026). Contemporary Perioperative Outcomes of Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer. Journal of Endourology, 40(7), 766-772. https://doi.org/10.1177/08927790261451073

Vancouver

Qian Z, Zhangxu K, Magnani CJ, D'Andrea VD, Barros GG, Guglielmetti GB, et al. Contemporary Perioperative Outcomes of Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer. Journal of Endourology. 2026;40(7):766-772. doi:10.1177/08927790261451073

BibTeX
@article{Qian2026,
  author = {Qian, Zhiyu and Zhangxu, Kevin and Magnani, Christopher J and D'Andrea, Vincent D and Barros, Guilherme Garcia and Guglielmetti, Giuliano B and Coelho, Rafael F and Mestre, Miguel Amer and Korn, Stephan and Zurl, Hanna and Pohl, Klara and Piccolini, Andrea and Mossanen, Matthew and Trinh, Quoc-Dien and Cole, Alexander P and Kibel, Adam S and Clinton, Timothy N},
  title = {Contemporary Perioperative Outcomes of Robotic Retroperitoneal Lymph Node Dissection for Testicular Cancer},
  journal = {Journal of Endourology},
  year = {2026},
  volume = {40},
  number = {7},
  pages = {766--772},
  doi = {10.1177/08927790261451073}
}
Kostenlos starten →